Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Glanzmann thrombasthenia: state of the art and future directions.

Seminars in thrombosis and hemostasis - 1 Sept 2013

Nurden Alan T, Pillois Xavier, Wilcox David A

Abstract excerpt

Glanzmann thrombasthenia (GT) is the principal inherited disease of platelets and the most commonly encountered disorder of an integrin. GT is characterized by spontaneous mucocutaneous bleeding and an exaggerated response to trauma caused by platelets that fail to aggregate when stimulated by physiologic agonists. GT is caused by quantitative or qualitative deficiencies of αIIbβ3, an integrin coded by the ITGA2B...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Blood Platelets
Share to Genetic Therapy
Share to Hemorrhage

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Mutation

Share to Platelet Glycoprotein GPIIb-IIIa Complex

Share to Stem Cell Transplantation

Share to Thrombasthenia

Share to Transplantation, Autologous

Source

Open in PubMed Open full text

Identifiers

PMID: 23929305
DOI: 10.1055/s-0033-1353393
PMCID: PMC4011384

Genes

ITGB3
EGF

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Glanzmann thrombasthenia: state of the art and future directions.PMID 23929305Read ↗

Glanzmann thrombasthenia: a review of ITGA2B and ITGB3 defects with emphasis on variants, phenotypic variability, and mouse models.Semantic proximity Read ↗

Profiling the Genetic and Molecular Characteristics of Glanzmann Thrombasthenia: Can It Guide Current and Future Therapies?Semantic proximity Read ↗

Understanding the genetic basis of Glanzmann thrombasthenia: implications for treatment.Semantic proximity Read ↗

Expanding the Mutation Spectrum Affecting αIIbβ3 Integrin in Glanzmann Thrombasthenia: Screening of the ITGA2B and ITGB3 Genes in a Large International Cohort.Semantic proximity Read ↗

Should studies on Glanzmann thrombasthenia not be telling us more about cardiovascular disease and other major illnesses?Semantic proximity Read ↗

Clinical and molecular insights into Glanzmann's thrombasthenia in China.Semantic proximity Read ↗

Glanzmann's Thrombasthenia: An OverviewSemantic proximity Read ↗

Characterisation of patients with Glanzmann thrombasthenia and identification of 17 novel mutations.Semantic proximity Read ↗

Two homozygous missense mutations in ITGB3 gene as a cause of Glanzmann Thrombasthenia in four consanguineous Pakistani pedigrees.Semantic proximity Read ↗

Genetic characterization of Glanzmann thrombasthenia: insights from novel igta2b mutations in a Tunisian patient cohort.Semantic proximity Read ↗

In silico analysis of structural modifications in and around the integrin αIIb genu caused by ITGA2B variants in human platelets with emphasis on Glanzmann thrombasthenia.Semantic proximity Read ↗

Molecular defects in ITGA2B and ITGB3 genes in patients with Glanzmann thrombasthenia.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.